NIB Holdings Ltd (ASX: NHF) Share Price and News

Price

$7.53

Movement

0.05 (+0.67%)

As at 19 Sep 3:09pm (20 mins delayed)

52 Week Range

$5.36 - $8.26

 
1 Year Return

+31.64%

NIB Holdings Ltd Chart and Price Data

$6
$8
$6
$8
$6
$8
$6
$8

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.64 billion
P/E Ratio 18.96
Dividend Yield 3.83%
Shares Outstanding 487.02 million
Earnings per share 0.400
Dividend per share 0.29
Year To Date Return 43.61%
Earnings Yield 5.27%
Franking 100%
Earnings Yield

5.27%

Franking

100%

Dividend per share

0.29

Year To Date Return

43.61%

Shares Outstanding

487.02 million

Earnings per share

0.400

Share Price

$7.53

Day Change

0.05 (+0.67%)

52 Week Range

$5.36 - $8.26

Yesterday's Close

$7.48

Today's Open

$7.52

Days Range

$7.50 - $7.565

Volume

381,201

Avg. Volume (1 month)

996,864

Turnover

$2,871,013

As at 19 Sep 3:09pm

  • NIB Holdings Ltd (ASX: NHF)
    Latest News

    Two lab workers fist pump each other.
    Healthcare Shares

    Overinvested in CSL? Here are two alternative ASX healthcare stocks

    I think these two stocks are healthy investment options.

    Read more »

    Two brokers analysing stocks.
    Broker Notes

    Analysts say these ASX 300 shares are buys with 14% to 25% upside

    Great returns could be on the cards for buyers of these shares according to analysts.

    Read more »

    A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
    Share Market News

    5 things to watch on the ASX 200 on Friday

    How will the Australian market finish the week? Let's find out.

    Read more »

    A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 notched up another record high this Thursday.

    Read more »

    A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
    Healthcare Shares

    Is this beaten-down ASX healthcare share a bargain buy now?

    One expert has given their view on this stock.

    Read more »

    Two brokers analysing stocks.
    Broker Notes

    Don't miss these changes to broker ratings on ASX shares

    The verdicts are in.

    Read more »

    Private health insurance diagram.
    Financial Shares

    Why did the NIB share price just hit a 3-year low?

    Investors reacted negatively to an announcement from the private health insurer.

    Read more »

    A young man goes over his finances and investment portfolio at home.
    Healthcare Shares

    Down 20%, is the NIB share price undervalued?

    Here's what Goldman Sachs is saying about this blue chip stock.

    Read more »

    Man looks confused as he works at his laptop. watching the Magnis share price movements
    Financial Shares

    Down 21% this year, are NIB shares a buy?

    Could this be the turning point?

    Read more »

    Happy young couple saving money in piggy bank.
    Dividend Investing

    How I'd build an ASX passive income portfolio with $10k

    Analysts think the six shares in this article are buys for income investors.

    Read more »

    ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,
    Healthcare Shares

    Here's why ASX 200 health insurance shares like Medibank are being trounced today

    Investors are feeling a bit sick after the latest update.

    Read more »

    Smiling couple looking at a phone at a bargain opportunity.
    Cheap Shares

    History says these 3 ASX shares are dirt cheap today

    These beaten-down ASX shares could be offering great value for money.

    Read more »

    Frequently Asked Questions

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2025 $0.1600 100.00% Final 07 Oct 2025
    06 Mar 2025 $0.1300 100.00% Interim 09 Apr 2025
    05 Sep 2024 $0.1400 100.00% Final 08 Oct 2024
    07 Mar 2024 $0.1500 100.00% Interim 10 Apr 2024
    04 Sep 2023 $0.1500 100.00% Final 03 Oct 2023
    02 Mar 2023 $0.1300 100.00% Interim 03 Apr 2023
    05 Sep 2022 $0.1100 100.00% Final 04 Oct 2022
    03 Mar 2022 $0.1100 100.00% Interim 04 Apr 2022
    02 Sep 2021 $0.1400 100.00% Final 05 Oct 2021
    04 Mar 2021 $0.1000 100.00% Interim 06 Apr 2021
    03 Sep 2020 $0.0400 100.00% Final 06 Oct 2020
    05 Mar 2020 $0.1000 100.00% Interim 07 Apr 2020
    02 Sep 2019 $0.1300 100.00% Final 30 Sep 2019
    06 Sep 2018 $0.1100 100.00% Final 05 Oct 2018
    01 Mar 2018 $0.0900 100.00% Interim 03 Apr 2018
    07 Sep 2017 $0.0000 100.00% Final 06 Oct 2017
    02 Mar 2017 $0.0850 100.00% Interim 03 Apr 2017
    08 Sep 2016 $0.0900 100.00% Final 07 Oct 2016
    02 Mar 2016 $0.0575 100.00% Interim 01 Apr 2016
    10 Sep 2014 $0.0900 100.00% Special Cash 03 Oct 2014
    10 Sep 2014 $0.0575 100.00% Final 03 Oct 2014
    05 Sep 2013 $0.0500 100.00% Final 04 Oct 2013
    04 Mar 2013 $0.0500 100.00% Interim 05 Apr 2013
    05 Mar 2012 $0.0425 100.00% Interim 05 Apr 2012
    07 Mar 2011 $0.0400 100.00% Interim 08 Apr 2011
    05 Mar 2010 $0.0200 100.00% Interim 08 Apr 2010
    14 Sep 2009 $0.0440 100.00% Final 09 Oct 2009

    NHF ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    8th Sep 2025 2025-09-08T15:25:48 Change of Director's Interest NoticeYesNo3:25pm3190k
    5th Sep 2025 2025-09-05T17:06:58 Ceasing to be a substantial holder from MUFGYesNo5:06pm731.2M
    5th Sep 2025 2025-09-05T14:02:58 Notification of cessation of securities - NHFYesNo2:02pm413k
    5th Sep 2025 2025-09-05T14:01:48 Notification regarding unquoted securities - NHFYesNo2:01pm616k
    5th Sep 2025 2025-09-05T13:59:08 Change of Director's Interest NoticeYesNo1:59pm6292k
    4th Sep 2025 2025-09-04T18:53:22 Ceasing to be a substantial holderYesNo6:53pm3618k
    26th Aug 2025 2025-08-26T16:42:14 Becoming a substantial holder from MUFGYesNo4:42pm2752.5M
    25th Aug 2025 2025-08-25T16:38:15 Becoming a substantial holderYesNo4:38pm9724k
    25th Aug 2025 2025-08-25T08:11:16 2025 Group Climate-Related DisclosureYesNo8:11am171.6M
    25th Aug 2025 2025-08-25T08:11:11 2025 Sustainability ReportYesNo8:11am538.4M

    About NIB Holdings Ltd

    NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.

    In addition, it covers more than 180,000 international students and workers in Australia.

    The company also offers travel insurance through its NIB Travel business,  and provides health insurance plans to corporate groups through its GU Health business.

    NHF Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 Sep 2025 $7.57 $-0.01 -0.13% 804,445 $7.54 $7.60 $7.51
    16 Sep 2025 $7.58 $-0.01 -0.13% 378,701 $7.60 $7.63 $7.50
    15 Sep 2025 $7.59 $0.06 0.80% 929,895 $7.53 $7.60 $7.47
    12 Sep 2025 $7.53 $0.07 0.94% 557,114 $7.50 $7.57 $7.47
    11 Sep 2025 $7.46 $0.02 0.27% 521,835 $7.43 $7.50 $7.36
    10 Sep 2025 $7.44 $0.13 1.78% 851,707 $7.31 $7.44 $7.29
    09 Sep 2025 $7.31 $0.00 0.00% 571,508 $7.31 $7.33 $7.29
    08 Sep 2025 $7.31 $-0.06 -0.81% 738,664 $7.30 $7.35 $7.23
    05 Sep 2025 $7.37 $0.04 0.55% 1,160,363 $7.40 $7.40 $7.31
    04 Sep 2025 $7.33 $-0.13 -1.74% 1,047,355 $7.42 $7.44 $7.28
    03 Sep 2025 $7.46 $-0.08 -1.06% 816,293 $7.49 $7.54 $7.42
    02 Sep 2025 $7.54 $-0.09 -1.18% 789,231 $7.58 $7.61 $7.50
    01 Sep 2025 $7.63 $-0.05 -0.65% 892,037 $7.63 $7.73 $7.58
    29 Aug 2025 $7.68 $0.22 2.95% 2,150,708 $7.46 $7.75 $7.40
    28 Aug 2025 $7.46 $-0.08 -1.06% 783,717 $7.55 $7.70 $7.37
    27 Aug 2025 $7.54 $-0.02 -0.26% 837,950 $7.62 $7.88 $7.48
    26 Aug 2025 $7.56 $-0.36 -4.55% 2,081,304 $7.89 $7.98 $7.54
    25 Aug 2025 $7.92 $0.21 2.72% 1,796,069 $7.92 $8.26 $7.83
    22 Aug 2025 $7.71 $0.01 0.13% 739,140 $7.70 $7.74 $7.65
    21 Aug 2025 $7.70 $0.13 1.72% 910,481 $7.63 $7.77 $7.62
    20 Aug 2025 $7.57 $0.05 0.66% 2,194,989 $7.55 $7.63 $7.53
    19 Aug 2025 $7.52 $-0.08 -1.05% 789,809 $7.58 $7.61 $7.51

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    04 Sep 2025 Jill Watts Buy 2,013 $14,936
    On-market trade.
    02 Sep 2025 Jill Watts Buy 4,660 $34,996
    On-market trade.
    01 Sep 2025 Edward Close Exercise 46,681 $356,176
    Conversion of securities. 253,206 Rights
    01 Sep 2025 Edward Close Issued 37,451 $285,751
    Conversion of securities.
    01 Sep 2025 Edward Close Issued 42,722 $325,968
    Conversion of securities.
    07 May 2025 Edward Close Sell 32,000 $220,145
    On-market trade.
    06 Dec 2024 Edward Close Issued 154,359 $865,953
    Issue of securities. 299,887 Rights
    22 Nov 2024 Jill Watts Buy 3,597 $19,999
    On-market trade.
    21 Nov 2024 Peter Harmer Buy 17,574 $100,149
    On-market trade.
    18 Nov 2024 Mark Fitzgibbon Sell 35,000 $201,202
    On-market trade.
    15 Nov 2024 Mark Fitzgibbon Sell 35,000 $203,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David L Gordon Non-Executive DirectorNon-Executive Chairman May 2020
    Mr Gordon has over 30 years of experience as a director of both public and private companies and in corporate advisory roles to Australian and international organizations. He brings knowledge of strategy development, mergers and acquisitions, as well as capital raisings, IPOs and joint ventures. David has held several senior roles with Freehills (now Herbert Smith Freehills Kramer) (Partner) and boutique investment bank Wentworth Associates. In addition, he founded an independent corporate advisory and investment firm, Lexicon Partners, in 2001.
    Ms Anne Joan Loveridge Non-Executive Director Feb 2017
    Ms Loveridge has more than 35 years of experience in the highly regulated financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. She has been a Non-Executive Director for ASX-listed entities in the financial services sector for more than nine years. She is a member of the Risk and Reputation Committee
    Mr Donal Paul O'Dwyer Non-Executive Director Mar 2016
    Mr O'Dwyer has knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. He has experience in business, science, engineering, manufacturing and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, having an understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson & Johnson) - initially as European President and later, when he located to the US, he served as Worldwide President. He is a member of the People Committee.
    Mr Peter Harmer Non-Executive Director Jul 2021
    Mr Harmer has over 40 years of experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He has an understanding of the global insurance and reinsurance markets and has driven the improvement of business and customer experiences through digital innovation. During his career, Peter accelerated digital engagement through re-examining customer journeys to understand pain points and introduced the right tools and technology to help improve the overall customer experience. Peter was formerly Chief Executive Officer of Insurance Australia Group (IAG), CGU Insurance, Aon Limited UK, Aon Risk Services Australia Pacific and Aon Re Australia and has led business growth agendas, major acquisitions, and industry roll-ups. He is the Chair of the Risk and Reputation Committee and a member of the People Committee.
    Ms Jacqueline Chow Non-Executive Director Apr 2018
    Mr Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. She has also led company-wide business transformation by driving productivity. She is Chair of the People Committee.
    Mr Brad Welsh Non-Executive Director Jul 2023
    Mr Welsh has spent more than a decade advising global resource companies, including Energy Resources of Australia and Rio Tinto, bringing both public sector and commercial skills to his role. Through his senior leadership roles in mining and energy, Brad has focused on operational efficiency, safety and building trust with stakeholders, including traditional landowners. Through media and senior advisory roles in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia, he has acquired an understanding of the public sector. He is a member of the Risk and Reputation Committee and the People Committee.
    Ms Jill Watts Non-Executive Director Jul 2023
    Ms Watts has more than 40 years of experience leading global businesses. She has worked across the private sector, with governments affecting public policy change, and private research institutes. She has experience working with companies with operations in Australia, the UK, France, and South Africa. Prior to returning to Australia in 2017, Jill was the Group CEO of the UK's private hospital group, BMI Healthcare, responsible for 60 facilities across the UK. Jill was also Group CEO of Ramsay Healthcare, UK. She has joined the Boards of global companies since returning to Australia. She is a member of the Risk and Reputation Committee.
    Mr Edward Close Chief Executive OfficerManaging Director Dec 2024
    Mr Close has experience in financial services and health insurance, having overseen P&L, distribution, customer, digital and marketing functions. Ed has previously held senior management roles at the Commonwealth Bank of Australia, where he worked across product management, strategy and customer engagement in the consumer banking division. He is a member of the Risk Committee.
    Ms Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary Apr 2013
    -
    Mr Jordan French Senior Corporate CounselJoint Company Secretary Aug 2017
    -
    James Barr Chief Executive - Australian Private Health Insurance
    -
    Martin Adlington Chief Executive - nib Thrive
    -
    Rob Hennin Chief Executive Officer - nib New Zealand
    -
    Nick Freeman Group Chief Financial Officer
    -
    Brendan Mills Group Chief Information Officer
    -
    Lauren Daniels Group Chief People Officer
    -
    Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary
    -
    Matthew Neat Group Executive - Strategy and Development
    -
    Jordan French Senior Corporate CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 101,122,953 20.76%
    Citicorp Nominees Pty Limited 56,960,720 11.70%
    J P Morgan Nominees Australia Pty Limited 46,369,538 9.52%
    BNP Paribas Noms Pty Ltd 10,665,898 2.19%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 3,764,848 0.77%
    National Nominees Limited 2,373,958 0.49%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,054,537 0.42%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 1,465,800 0.30%
    HSBC Custody Nominees (Australia) Limited i 1,347,857 0.28%
    Netwealth Investments Limited <Wrap Services A/C> 1,250,920 0.26%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 1,183,793 0.24%
    First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> 1,145,778 0.24%
    Cpu Share Plans Pty Ltd <Nhf Escrow Trust Master A/C> 966,792 0.20%
    Ioof Investment Services Limited <Ips Superfund A/C> 803,376 0.16%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 755,044 0.16%
    BNP Paribas Nominees Pty Ltd <Agency Lending Collateral> 703,400 0.14%
    Fitzy (Nsw) Pty Ltd <Fitz Family Fund A/C> 546,621 0.11%
    Netwealth Investments Limited <Super Services A/C> 522,187 0.11%
    BNP Paribas Noms (Nz) Ltd 433,540 0.09%
    IOOF Investment Services Limited <IOOF IDPS A/C> 424,466 0.08%

    Profile

    since

    Note